EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioprospecting of serratiopeptidase-producing bacteria from different sources

Sreelakshmi R Nair, C Subathra Devi

Frontiers in Microbiology · 09.05.2024 · 15

DOI: 10.3389/fmicb.2024.1382816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.05.2024. Verfasst von Sreelakshmi R Nair und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-inflammatory enzymes have wide applications in the pharmaceutical industry. The objective of this study was to find new and efficient strains for the commercial production of serratiopeptidase enzyme. Vast number of samples were processed for the isolation of potent strains. The experimental treatment includes processing of twenty soil samples, silkworm gut, and sugarcane stem. The total protein and protease activity was estimated by Lowry’s method and casein hydrolysis. The HRBC stabilization assay was performed for finding the anti-inflammatory potential of all strains. The serratiopeptidase production was confirmed by HPLC with the standard. Molecular characterization of selected potent strains was done by 16S rDNA and confirmed the taxonomy. The one step rapid purification of serratiopeptidase was performed by Ultra three phase partitioning method. The clot lysis potential of the Serratia marcescens VS56 was observed by modified Holmstorm method. The results of the study revealed that among the 60 strains, 12 strains were protease-positive on skim milk agar plates and showed significant protease activity. All 12 strains were screened for serratiopeptidase using high-performance liquid chromatography (HPLC) and VS56, VS10, VS12 and VS18 showed a similar retention time (4.66 ± 0.10 min) with standard. The selected potent strain, Serratia marcescens VS56 showed a proteolytic activity of 21.30 units/mL and produced a total protein of 102 mg/mL. The HRBC suspension results also showed a percentage of 94.6 ± 1.00 protection, which was compared to the standard diclofenac. The clot lysis potential of Serratia marcescens VS56 was 53% in 4 h. Furthermore, the molecular weight of the protein was identified to confirm the presence of serratiopeptidase. The study hence contributed successfully to isolating, screening, and identifying a potent producer for serratiopeptidase from an environmental source. This inherent advantage of the strain will undoubtedly contribute much to the coco comm commercial production of serratiopeptidase in the near future.

Schlagwörter

Stichwörter der Autor:innen

SDS-PAGESerratia marcescensanti-inflammatory drugsfibrinolytic proteaseserratiopeptidase

Autor:innen und Institutionen

  • Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Zitieren

APA

Nair, S. R., & Subathra Devi, C. (2024). Bioprospecting of serratiopeptidase-producing bacteria from different sources. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1382816

Vancouver

Nair SR, Subathra Devi C. Bioprospecting of serratiopeptidase-producing bacteria from different sources. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1382816

BibTeX
@article{Nair2024,
  author = {Nair, Sreelakshmi R and Subathra Devi, C},
  title = {Bioprospecting of serratiopeptidase-producing bacteria from different sources},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1382816}
}
Kostenlos starten →